Explanation of the 7 clinical questions in Japanese gastric cancer treatment guidelines--the 4th edition 2014
CHEN Jun-qing
Abstract：Japanese gastric cancer treatment guide lines-the 4th Edition has proposed a solution for 3 kinds of patients with resectable M1 disease and without any other non-curative factors. They are scheduled to receive combined treatment-operation and chemotherapy. For example, patients who are scheduled to receive gastrectomy with extended lymphadenectomy (No.16a2、b1). Patients with CY1 disease, who are proposed to receive radical resection as routines, have achieved better results, combined with paraoperational chemotherapy. Patients with a small number of liver metastases are recommended with surgical therapy combined with systemic treatment. The guide provided effective treatments, which deserve attention, considered for patients with four kinds of advanced gastric cancer that are not applicable to standard chemotherapy.
Keywords：gastric carcinomaNo.16a2、b1 lymph nodeperitoneal cytology positivechemotherapy
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 357-359,435 )